# Episode 499: APCCC 2026 - Radioligands in Prostate Cancer Page: https://stenobird.com/podcast/the-uromigos-1214845/episode-499-apccc-2026-radioligands-in-prostate-cancer Text version: https://stenobird.com/podcast/the-uromigos-1214845/episode-499-apccc-2026-radioligands-in-prostate-cancer.md Podcast: [The Uromigos](https://stenobird.com/podcast/the-uromigos-1214845) Published: 2026-05-25T14:43:37+00:00 Episode link: https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-499-APCCC-2026---Radioligands-in-Prostate-Cancer-e3jsav8 Audio file: https://anchor.fm/s/13347ea8/podcast/play/120514984/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-4-25%2F424852580-44100-2-46a63ba4af103.m4a Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-499-apccc-2026-radioligands-in-prostate-cancer Duration seconds: 2238 ## Resource This session features expert Michael Morris discussing radioligand therapy, adaptive dosing, retreatment strategies, and the latest insights in prostate cancer treatment. Gain a deep understanding of current practices, challenges, and future directions in radiopharmaceuticals. ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-499-apccc-2026-radioligands-in-prostate-cancer/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/the-uromigos-1214845/episode-499-apccc-2026-radioligands-in-prostate-cancer.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.